CVS Health (CVS) Selloff Was Driven by "Nit-Picky Dynamics", BofA Only Moves FY EPS by 2c, Reiterates Buy

February 17, 2021 7:51 AM EST Send to a Friend
BofA Securities analyst Michael Cherny reiterated a Buy rating and $90.00 price target on CVS Health (NYSE: CVS) believing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login